Sign up for free insights newsletter
AR

Alexandria Real Estate Equities Inc

AREUnited States

Need professional-grade analysis? Visit stockanalysis.com

$47.39
-1.90%
End of day
Market Cap

$8.39B

P/E Ratio

N/A

Employees

514

Dividend Yield

9.31%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino0.01-1.60-1.36-0.80-1.01
Calmar0.01-1.44-0.94-0.25-0.69
Sharpe0.00-1.43-1.16-0.61-0.86
Omega1.030.640.770.910.83
Martin0.02-1.99-1.58-0.45-1.06
Ulcer8.7734.3730.6542.6131.18

Alexandria Real Estate Equities Inc (ARE) Price Performance

Alexandria Real Estate Equities Inc (ARE) trades on United States in USD. The company is classified in the Real Estate sector under the REIT - Office industry. The stock currently trades at $47.39, down 1.90% from the previous close.

Over the past year, ARE has traded between a low of $44.32 and a high of $90.31. The stock has lost 47.4% over this period. It is currently 47.5% below its 52-week high.

Alexandria Real Estate Equities Inc has a market capitalization of $8.39B and a dividend yield of 9.31%.

About Alexandria Real Estate Equities Inc

Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of $20.75 billion and an asset base in North America that includes 35.9 million RSF of operating properties and 3.5 million RSF of Class A/A+ properties undergoing construction. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Mega campus environments that enhance our tenant ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$3.02B
EBITDA
$1.94B
Profit Margin
-47.38%
EPS (TTM)
0.60
Book Value
90.71

Technical Indicators

52 Week High
$91.75
52 Week Low
$43.46
50 Day MA
$53.88
200 Day MA
$65.96
Beta
1.32

Valuation

Trailing P/E
N/A
Forward P/E
16.69
Price/Sales
2.78
Price/Book
0.54
Enterprise Value
$21.92B